Agilent's Bio-Analytical Fiscal Q1Revenues Rise 22 Percent as Life Sciences Grows 23 Percent

Feb 16, 2007

NEW YORK (GenomeWeb News) — Agilent Technologies said late yesterday that fiscal first-quarter revenues increased 10 percent as R&D spending increased 1.8 percent and profit declined after a divestiture during the same period last year caused the company to report a large gain.

Total receipts for the three months ended Jan. 31 increased to $1.25 billion from $1.17 billion year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Keep on Brushing

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Panda Gut Seasonality

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

This Week in PLOS

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Main menu